Mary Mehlig

829 total citations
9 papers, 473 citations indexed

About

Mary Mehlig is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Mehlig has authored 9 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Mehlig's work include Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and RNA Interference and Gene Delivery (2 papers). Mary Mehlig is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and RNA Interference and Gene Delivery (2 papers). Mary Mehlig collaborates with scholars based in United States and Italy. Mary Mehlig's co-authors include Hong Zhao, Lee M. Greenberger, Ivan D. Horak, Patricia Kraft, Puja Sapra, Clifford Longley, Virna Borowski, Gerrit Borchard, Maksim Royzen and Dee Wu and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Mary Mehlig

9 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Mehlig United States	7	299	164	102	99	79	9	473
Khalid Abu Ajaj Germany	12	222 0.7×	155 0.9×	163 1.6×	88 0.9×	39 0.5×	16	497
Péter Lázár Hungary	7	185 0.6×	122 0.7×	146 1.4×	55 0.6×	73 0.9×	9	426
Giulia Pellizzari United Kingdom	8	253 0.8×	105 0.6×	160 1.6×	111 1.1×	38 0.5×	12	570
M. Farao Italy	7	236 0.8×	166 1.0×	128 1.3×	72 0.7×	27 0.3×	9	399
Henrike Caysa Germany	13	211 0.7×	225 1.4×	115 1.1×	237 2.4×	41 0.5×	15	662
James R. Kintzing United States	7	481 1.6×	100 0.6×	86 0.8×	66 0.7×	30 0.4×	10	639
Paul J. Kleindl United States	14	378 1.3×	105 0.6×	214 2.1×	60 0.6×	36 0.5×	19	697
Fengxi Liu China	11	291 1.0×	264 1.6×	55 0.5×	172 1.7×	53 0.7×	23	554
Euan C. Ramsay Canada	8	350 1.2×	211 1.3×	117 1.1×	142 1.4×	34 0.4×	9	552
Maneesh Gujrati United States	9	429 1.4×	110 0.7×	72 0.7×	94 0.9×	116 1.5×	10	580

Countries citing papers authored by Mary Mehlig

Since Specialization

Citations

This map shows the geographic impact of Mary Mehlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Mehlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Mehlig more than expected).

Fields of papers citing papers by Mary Mehlig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Mehlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Mehlig. The network helps show where Mary Mehlig may publish in the future.

Co-authorship network of co-authors of Mary Mehlig

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Mehlig. A scholar is included among the top collaborators of Mary Mehlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Mehlig. Mary Mehlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sapra, Puja, Patricia Kraft, Fabio Pastorino, et al.. (2011). Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects. Angiogenesis. 14(3). 245–53. 61 indexed citations

Sapra, Puja, Patricia Kraft, Mary Mehlig, et al.. (2009). Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma. Haematologica. 94(10). 1456–1459. 24 indexed citations

Sapra, Puja, Hong Zhao, Mary Mehlig, et al.. (2008). Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11–Refractory Model. Clinical Cancer Research. 14(6). 1888–1896. 136 indexed citations

Sapra, Puja, Mary Mehlig, Patricia Kraft, et al.. (2007). Marked Therapeutic Efficacy of a Novel Polyethyleneglycol-SN38 Conjugate, EZN-2208, in Xenograft Models of Non-Hodgkin’s Lymphoma.. Blood. 110(11). 1397–1397. 1 indexed citations

Zhao, Hong, Ping Peng, Clifford Longley, et al.. (2006). Delivery of G3139 using releasable PEG-linkers: Impact on pharmacokinetic profile and anti-tumor efficacy. Journal of Controlled Release. 119(2). 143–152. 17 indexed citations

Sapra, Puja, D Filpula, Mary Mehlig, et al.. (2006). 160 POSTER In vitro and in vivo evaluation of pegaspargase for the treatment of solid tumors and lymphomas. European Journal of Cancer Supplements. 4(12). 51–51. 1 indexed citations

Yu, Deshan, Ping Peng, S. Dharap, et al.. (2005). Antitumor activity of poly(ethylene glycol)–camptothecin conjugate: The inhibition of tumor growth in vivo. Journal of Controlled Release. 110(1). 90–102. 95 indexed citations

Yang, Kaiyong, Anirban Basu, H. Wang, et al.. (2003). Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation. Protein Engineering Design and Selection. 16(10). 761–770. 86 indexed citations

Choe, Yun H., Cheryl A. Conover, Dee Wu, et al.. (2002). Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C.II. Efficacy in ascites and solid tumors. Journal of Controlled Release. 79(1-3). 55–70. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact